Pharmaceutical Industry Information Portal


All posts by tag


Petrovax began supplying quadrivalent influenza vaccine to the Russian market and abroad

The total supply of the vaccine for Russian and foreign markets in 2022 will amount to more than 2.5 million doses

Petrovax pharmaceutical company received a patent for Longidase® in South Korea

Petrovax has received a patent for the original medicine product Longidaza®, which is valid in South Korea protecting. During the COVID-19 pandemic, the drug product...

Russia’s Petrovax ready to produce inhalable version of the Convidecia coronavirus vaccine

The launch of the project for the production of the inhalable version of the vaccine will depend on the registration of the injectable form...

Russian drug Longidaza® to help cope with post-Covid is patented in India

Longidaza®, developed in Russia, received a patent in India. This was reported by the company "Petrovax". Thus, Longidasa, which already has patents in a...

Petrovax presents its products in Europe

Russian pharmaceutical company Petrovax is expanding its export portfolio and considering new markets for its pharmaceuticals and vaccines. At CPHI Worldwide 2021, an international...

Russian original medicine product Longidaza® has been patented in Europe

Petrovax Pharm LLC has received a European patent for the original medicine product Longidaza®, which is valid in the UK, Germany, France, Switzerland, Ireland,...

Expert Articles